Oral solid doses (OSD) are the mainstay of pharmaceutical delivery systems. Yet manufacturing the different types of tablets, capsules, beads, powders, and granules requires proven skills, knowledge, and technologies.
Manufacturing 275 million solid doses annually, LGM Pharma is a proven CDMO partner for your next orally ingested therapeutic. With a heritage dating back to the 1940s, we bring a complete set of technologies and capabilities to expertly manufacture your solid dose delivery system – whether a simple tablet or more sophisticated solid dosage form.
Trust LGM to manufacture all types of solid dose pharmaceuticals:
Access the comprehensive selection of manufacturing techniques to deliver high-quality OSD forms:
LGM also offers various solid dose packaging solutions, and operational track and trace capabilities and serialization equipment.
Long before the FDA established Quality by Design practices, LGM Pharma bred quality into the development of our manufacturing and production processes. Whether we formulate your OSD or transfer it in, manufacturing protocols are developed, validated, and enforced. This ensures Critical Quality Attributes are maintained for a reproducibly safe, efficacious, and stable finished product.
From securing high-quality active pharmaceutical ingredients (API) to manufacturing finished drug product, LGM Pharma can bring your OSD to market.
Your solid dose delivery system can be expertly formulated, including R&D manufacturing, at our Colorado Springs, CO facility and tech transferred for manufacturing and packaging at our cGMP facility in Irvine, CA. In-house analytical testing services are also part of your CDMO engagement.
Our state-of-the-art facilities are fully licensed and accredited for GMP and cGMP manufacturing. FDA inspections and annual customer audits reveal no current issues or observations.
Unique Outsourcing Models
At LGM Pharma, you’re more than a customer. We’re partners – and successful partnerships have “win-win” outcomes. That’s why we offer standard fee-for-service packages, joint-venture partnerships, and risk/profit-sharing models.